Labex Canada Inc.

The company began as a Global Business Development firm, supporting medical and IVD product manufacturers in introducing their innovations to international markets.

In 2015, the company expanded its activities to include the design and planning of hospitals, laboratories, and healthcare centers, offering top-quality and timely implementation of complex construction projects, modular systems, and clean rooms.

By 2019, Labex evolved into a manufacturing company, and in 2021 successfully obtained MDSAP and ISO 13485:2016 certifications, ensuring compliance with the highest quality standards.

Today, Labex is recognized as a manufacturer of fully automated IHC stainers and FISH instruments, along with their associated reagents and a comprehensive range of primary antibodies. Products are licensed by Health Canada and CE-marked for distribution across European and other international markets.The company began as a Global Business Development firm, supporting medical and IVD product manufacturers in introducing their innovations to international markets. In 2015, the company expanded its activities to include the design and planning of hospitals, laboratories, and healthcare centers, offering top-quality and timely implementation of complex construction projects, modular systems, and clean rooms. By 2019, Labex evolved into a manufacturing company, and in 2021 successfully obtained MDSAP and ISO 13485:2016 certifications, ensuring compliance with the highest quality standards. Today, Labex is recognized as a manufacturer of fully automated IHC stainers and FISH instruments, along with their associated reagents and a comprehensive range of primary antibodies. Products are licensed by Health Canada and CE-marked for distribution across European and other international markets.